Expression and prognostic significance of Tetranectin in invasive and non-invasive bladder cancer

Virchows Archiv

Volumn 450, Issue 6, 2007, Pages 659-664

  Brunner, A ^a   Ensinger, C ^a   Christiansen, M ^b   Heiss, S ^a   Verdorfer, I ^a   Mikuz, G ^a   Tzankov, A ^c  

^a MEDICAL UNIVERSITY OF INNSBRUCK   (Austria)

^b STATENS SERUM INSTITUT   (Denmark)

^c UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Prognosis; Tetranectin; Transitional cell carcinoma

Indexed keywords

TETRANECTIN;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER DIAGNOSIS; CANCER GRADING; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TISSUE MICROARRAY; TRANSITIONAL CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; LECTINS, C-TYPE; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RISK ASSESSMENT; STAINING AND LABELING; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 34250808455     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-007-0409-4     Document Type: Article

References (27)

1. Arvanitis DL, Kamper EF, Kopeikina L, Stavridou A, Sgantzos MN, Kallioras V, Athanasiou E, Kanavaros P (2002) Tetranectin expression in gastric adenocarcinomas. Histol Histopathol 17:471-475
2. Borregaard N, Christensen L, Bejerrum OW, Birgens HS, Clemmensen I (1990) Identification of a highly mobilizable subset of human neutrophil intracellular vesicles that contains tetranectin and latent alkaline phosphatase. J Clin Invest 85:408-416
3. Caterer NR, Graversen JH, Jacobsen C, Moestrup SK, Sigurskjold BW, Etzerodt M, Thogersen HC (2002) Specificity determinants in the interaction of apolipoprotein(a) kringles with tetranectin and LDL. Biol Chem 383:1743-1750
4. Christensen L (1992) The distribution of fibronectin, laminin and tetranectin in human breast cancer with special attention to the extracellular matrix. APMIS Suppl 26:1-39
5. Christensen L, Clemmensen I (1989) Tetranectin immunoreactivity in normal human tissues. An immunohistochemical study of exocrine epithelia and mesenchyme. Histochemistry 92:29-35
6. Christensen L, Clemmensen I (1991) Differences in tetranectin immunoreactivity between benign and malignant breast tissue. Histochemistry 95:427-433
7. Christensen L, Johansen N, Jensen BA, Clemmensen I (1987) Immunohistochemical localization of a novel, human plasma protein, tetranectin, in human endocrine tissues. Histochemistry 87:195-199
8. Clemmensen I, Lund LR, Christensen L, Andreasen PA (1991) A tetranectin-related protein is produced and deposited in extracellular matrix by human embryonal fibroblasts. Eur J Biochem 195:735-741
9. Clemmensen I, Petersen LC, Kluft C (1986) Purification and characterization of a novel, oligomeric, plasminogen kringle 4 binding protein from human plasma: tetranectin. Eur J Biochem 156:327-333
10. De Vries TJ, De Wit PE, Clemmensen I, Verspaget HW, Weidele UH, Bröcker EB, Ruiter DJ, Van Muijen GNP (1996) Tetranectin and plasmin/plasminogen are similarly distributed at the invasive front of cutaneous melanoma lesions. J Pathol 179:260-265
11. Hogdall CK, Christensen L, Clemmensen I (1993) The prognostic value of tetranectin immunoreactivity and plasma tetranectin in patients with ovarian cancer. Cancer 72:2415-2422
12. Hogdall CK, Christiansen M, Nogaard B, Bentzen SM, Kronenberg O, Clemmensen I (1995) Plasma tetranectin and colorectal cancer. Eur J Cancer 31:888-894
13. Hogdall CK, Hogdall EV, Hording U, Daugaard S, Clemmensen I, Norgaard-Pedersen B, Toftager-Larsen K (1991) Plasma tetranectin and ovarian neoplasms. Gynecol Oncol 43:103-107
14. Kamper EF, Kopeikina LT, Trontzas P Kyrazis NC, Vaiopoulos G, Stavridis J (1998) Comparative study of tetranectin levels in serum and synovial fluid of patients with rheumatoid arthritis, seronegative spondylarthritis and osteoarthritis. Clin Rheumatol 17:318-324
15. Kluft C, Jie AF, Los P, de Wit E, Havekes L (1989) Functional analogy between lipoprotein(a) and plasminogen in the binding to the kringle 4 binding protein, tetranectin. Biochem Biophys Res Commun 15(161):427-433
16. Kluft C, Los P, Clemmensen I, Brommer EJP, Leuven JAG, Bogs AL, Vellenga E (1989) Quantitation of plasma levels of tetranectin-effects of oral contraceptives, pregnancy, treatment with l-asparaginase and liver cirrhosis. Thromb Haemost 62:792-796
17. Lorentsen RH, Graversen JH, Caterer NR, Thogersen HC, Etzerodt M (2000) The heparin-binding site in tetranectin is located in the N-terminal region and binding does not involve the carbohydrate recognition domain. Biochem J 347(Pt 1):83-87
18. Mogues T, Etzerodt M, Hall C, Engelich G, Graversen JH, Hartshorn KL (2004) Tetranectin binds to the kringle 1-4 form of angiostatin and modifies its functional activity. J Biomed Biotechnol 2:73-78
19. Montironi R, Lopez-Beltran A (2005) The 2004 WHO classification of bladder tumors: a summary and commentary. Int J Surg Pathol 13:143-153
20. Nielsen H, Clemmensen I, Kharazmi A (1993) Tetranectin: a novel secretory protein from human monocytes. Scand J Immunol 37:39-42
21. Obrist P, Spizzo G, Ensinger C, Fong D, Brunhuber T, Schäfer G, Varga M, Margreiter R, Amberger A, Gastl G, Christiansen M (2004) Aberrant tetranectin expression in human breast carcinomas as a predictor of survival. J Clin Pathol 57:417-421
22. Tzankov A, Went P, Zimpfer A, Dirnhofer S (2005) Tissue microarray technology: principles, pitfalls and perspectives-lessons learned from hematological malignancies. Exp Gerontol 40:737-744
23. Verspaget HW, Clemmensen I, Ganesh S, Christensen L, Sier CFM, Griffioen G, Lamers CBHW (1995) Tetranectin expression in human colonic neoplasia. Histopathology 25:463-746
24. Westergaard UB, Andersen MH, Heegaard CW Fedosov SN, Petersen TE (2003) Tetranectin binds hepatocyte growth factor and tissue-type plasminogen activator. Eur J Biochem 270:1850-1854
25. Wewer UM, Albrechtsen R (1992) Tetranectin, a plasminogen kringle 4-binding protein. Cloning and gene expression pattern in human colon cancer. Lab Invest 67:253-26
26. Wewer UM, Iba K, Durkin ME, Nielsen FC, Loechel F, Gilpin BJ, Kuang W, Engvall E, Albrechtsen R (1998) Tetranectin is a novel marker for myogenesis during embryonic development, muscle regeneration, and muscle cell differentiation in vitro. Dev Biol 200:247-259
27. Wewer UM, Ibaraki K, Schjorring P, Durkin ME, Young MF, Albrechtsen R (1994) A potential role for tetranectin in mineralization during osteogenesis. J Cell Biol 127:1767-1775